The Clinical Core operates as the unit of the Oregon Alzheimer's Disease Center (OADC) with responsibility for identification, recruitment, characterization, and follow-up of populations of well-characterized subjects for clinical research. In keeping with the OADC focus, the Clinical Core is organized to optimize research, leading to better defining normal aging and the transitions to mild cognitive impairment (MCI) and early dementia. In order to fulfill this mission, the Clinical Core completes systematic assessments resulting in standardized diagnoses of the research cohorts, which are then entered into the relational database of the OADC. Many types of data are collected in order to be responsive to current and anticipated needs of the research community: clinical histories, neurological examinations, MRI brain images, neuropsychological and behavioral assessments, and laboratory data. The Clinical Core works closely with the other cores of the Center to ensure tissue donations (Neuropathology Core), characterization of biomarkers and genetic associations (Biomarkers and Genetics Core) and smooth transfer, entry, storage and retrieval for analysis of the data (Data Management and Statistics Core). The Clinical Core faculty acts as an important knowledge resource, participating in Education and Information Core educational activities and programs. The Clinical Core is dedicated to on-going evaluation of its identified cohorts and to ensuring that subjects are not lost to follow-up. Several groups form a particular focus of the Clinical Core: 1) early Alzheimer's disease and related dementias;2) non-cognitively impaired or MCI elderly at high risk for developing dementia, emphasizing the oldest old;and 3) subjects reflecting social and racial diversity (African American and isolated rural populations) through the Satellite program. These subject groups and the research resources they create are used for a wide range of studies, including the natural history of aging without cognitive impairment, detection of cognitive decline with unobtrusive in-home monitoring technologies, the genetics of incipient dementia, biomarkers of underlying disease, and novel treatment or prevention regimens for cognitive decline. Implicit in this core is a fundamental commitment to research collaboration both within our local pool of talented investigators, as well as with our colleagues among the larger community of scientists at other ADC's and other relevant research institutions.

Public Health Relevance

The OADC Clinical Core provides the key research faculty, staff, and subject volunteers for the complete characterization of subjects involved in research focused on advancing the clinical science of detection, diagnosis and treatment of early cognitive decline. This ready clinical resource and infrastructure are intended to facilitate research in a manner that is widely shared, collaborative and responsive to the rapid development of knowledge about early dementia or the years before symptoms fully develop.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-24
Application #
8460023
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
24
Fiscal Year
2013
Total Cost
$118,776
Indirect Cost
$41,648
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Petersen, Johanna; Austin, Daniel; Kaye, Jeffrey A et al. (2014) Unobtrusive in-home detection of time spent out-of-home with applications to loneliness and physical activity. IEEE J Biomed Health Inform 18:1590-6
Wertheimer, Anne M; Bennett, Michael S; Park, Byung et al. (2014) Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 192:2143-55
Kilgour, Alixe H M; Todd, Oliver M; Starr, John M (2014) A systematic review of the evidence that brain structure is related to muscle structure and their relationship to brain and muscle function in humans over the lifecourse. BMC Geriatr 14:85
Shinto, Lynne; Quinn, Joseph; Montine, Thomas et al. (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis 38:111-20
Gray, Nora E; Morré, Jeff; Kelley, Jeremiah et al. (2014) Caffeoylquinic acids in Centella asiatica protect against amyloid-? toxicity. J Alzheimers Dis 40:359-73
Li, Ge; Millard, Steven P; Peskind, Elaine R et al. (2014) Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol 71:742-51
Davis, Melinda M; Freeman, Michele; Kaye, Jeffrey et al. (2014) A systematic review of clinician and staff views on the acceptability of incorporating remote monitoring technology into primary care. Telemed J E Health 20:428-38
Thielke, Stephen M; Mattek, Nora C; Hayes, Tamara L et al. (2014) Associations between observed in-home behaviors and self-reported low mood in community-dwelling older adults. J Am Geriatr Soc 62:685-9
Peskind, Elaine R; Li, Ge; Shofer, Jane B et al. (2014) Influence of lifestyle modifications on age-related free radical injury to brain. JAMA Neurol 71:1150-4
Millard, Steven P; Lutz, Franziska; Li, Ge et al. (2014) Association of cerebrospinal fluid A*42 with A2M gene in cognitively normal subjects. Neurobiol Aging 35:357-64

Showing the most recent 10 out of 225 publications